Omkar Pharmachem (BOM:532167) Total Receivables: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532167 Omkar Pharmachem Ltd BOM:532167
43 GF Score
Price ₹7.45
! 3 Warning Signs
View Full Analysis

What is Omkar Pharmachem Total Receivables?

Omkar Pharmachem BOM:532167 -1.59% 43 Total Receivables is ₹0.00 Mil as of Jun. 2026. GuruFocus rates BOM:532167 with a GF Score™ of 43/100. The stock has 3 warning signs investors should review.

Omkar Pharmachem's Total Receivables for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

Omkar Pharmachem Total Receivables Related Terms

Omkar Pharmachem Total Receivables Historical Data

* Premium members only.

The historical data trend for Omkar Pharmachem's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omkar Pharmachem Total Receivables Chart

Omkar Pharmachem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.49 0.49 0.97 0.32

Omkar Pharmachem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.97 0.00 0.32 0.00
BOM:532167
43GF Score
Omkar Pharmachem Ltd BOM:532167
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omkar Pharmachem Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹0.00 Mil mean?
Omkar Pharmachem (BOM:532167) has a Total Receivables of ₹0.00 Mil as of Jun. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Omkar Pharmachem and its competitors.
Is Omkar Pharmachem's Total Receivables too high?
Omkar Pharmachem's current Total Receivables is ₹0.00 Mil. Overall, Omkar Pharmachem has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Omkar Pharmachem's Total Receivables compare to CTAS and CPRT?
Omkar Pharmachem's Total Receivables of ₹0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Business Services company?
A good Total Receivables depends on the Business Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Omkar Pharmachem and its competitors. Omkar Pharmachem's current Total Receivables is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omkar Pharmachem stock overvalued right now?
Omkar Pharmachem (BOM:532167) has a current Total Receivables of ₹0.00 Mil. The current Total Receivables is ₹0.00 Mil. Omkar Pharmachem's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Omkar Pharmachem (BOM:532167), the current Total Receivables is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omkar Pharmachem Business Description

Address 310, Wall Street-1, 4th Floor, Ellisbridge, Near Gujarat College Cross Road, Ahmedabad, GJ, IND, 380006
Omkar Pharmachem Ltd is an India based company engaged in the provision of business support services.
43GF Score

Get the complete analysis for BOM:532167

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.45
Price